Latest News
KKR Closes USD 5.57bn Acquisition of US Post-Acute Care Provider Envision Healthcare
Friday 12 October 2018

12 October 2018 - US-based investment firm KKR (NYSE: KKR) has closed its acquisition of US-based healthcare services provider Envision Healthcare Corp. (NYSE: EVHC), the firm said.

As a result of the completion of the merger, Envision has become a wholly owned subsidiary of funds affiliated with KKR, and Envision stockholders will receive an amount in cash equal to USD 46.00 per share of Envision common stock.

This deal is worth USD 5.57bn, or USD 9.9bn including debt. It was announced in June.

Shares of Envision's common stock haveceased trading on the NYSE.

Envision Healthcare is a provider of physician-led services and post-acute care, and ambulatory surgery services.

At 30 June, the company offered physician services, primarily in the areas of emergency department and hospitalist services, anesthesiology services, radiology/tele-radiology services, and children's services to more than 1,800 clinical departments in healthcare facilities in 45 states and the District of Columbia.

Post-acute care is delivered through an array of clinical professionals and integrated technologies which, when combined, contribute to efficient and effective population health management strategies.

The company owns and operates 261 surgery centers and one surgical hospital in 35 states and the District of Columbia, with medical specialties ranging from gastroenterology to ophthalmology and orthopedics.

In total, the company offers a differentiated suite of clinical solutions on a national scale, creating value for health systems, payors, providers and patients.

KKR is a global investment firm that manages multiple alternative asset classes, including private equity, growth equity, energy, infrastructure, real estate and credit, with strategic manager partnerships that manage hedge funds.

The firm invests its own capital alongside the capital it manages for fund investors and provides financing solutions and investment opportunities through its capital markets business.
Date Published: 12/10/2018
Target: Envision Healthcare Corp
Country: USA
Deal Size: 5.57bn (USD)
Sector: Healthcare
Type: LBO
Financing: Cash
Status: Closed
Buyer: KKR